[
  {
    "ts": null,
    "headline": "Trump Trade: Reciprocal tariffs still to start on April 2",
    "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: RECIPROCAL TARIFFS: President Donald Trump intends for new reciprocal tariff rates to start on April 2, Andrea Shalal and David Lawder of Reuters report. “The intent is to enact tariffs on April 2,” a white house official said, according to the publication. “Unless the tariff and non-tariff barri",
    "url": "https://finnhub.io/api/news?id=1fb98fafa6e26a50cb813074f816f6d46993b58c90b1e0832c973e130c8fda5b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742479258,
      "headline": "Trump Trade: Reciprocal tariffs still to start on April 2",
      "id": 133323810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: RECIPROCAL TARIFFS: President Donald Trump intends for new reciprocal tariff rates to start on April 2, Andrea Shalal and David Lawder of Reuters report. “The intent is to enact tariffs on April 2,” a white house official said, according to the publication. “Unless the tariff and non-tariff barri",
      "url": "https://finnhub.io/api/news?id=1fb98fafa6e26a50cb813074f816f6d46993b58c90b1e0832c973e130c8fda5b"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025",
    "summary": "If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE).  The pharmaceutical giant isn't as risky an investment as it may appear to be.  Here are three reasons why Pfizer could prove to be a steal of a deal this year.",
    "url": "https://finnhub.io/api/news?id=3b52f7ac9c6ba608397f9eaab6842906bd4297a1e910fddfdbc48dd18fc20eb6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742478300,
      "headline": "3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025",
      "id": 133325256,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE).  The pharmaceutical giant isn't as risky an investment as it may appear to be.  Here are three reasons why Pfizer could prove to be a steal of a deal this year.",
      "url": "https://finnhub.io/api/news?id=3b52f7ac9c6ba608397f9eaab6842906bd4297a1e910fddfdbc48dd18fc20eb6"
    }
  },
  {
    "ts": null,
    "headline": "2 High-Yield Dividend Stocks That Are Bargain Buys Right Now",
    "summary": "Read on to find out why dividend seekers can confidently add Pfizer and Bristol Myers Squibb to their portfolios.  Pfizer has encountered some issues in recent years.  Sales of its coronavirus products fell off a cliff, and some of the company's older products are no longer the growth drivers they once were.",
    "url": "https://finnhub.io/api/news?id=e49c07fda0ea661a6e5e81095dc92044593bc5d97f96fe842cb5e9c09868ab3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742475600,
      "headline": "2 High-Yield Dividend Stocks That Are Bargain Buys Right Now",
      "id": 133325258,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Read on to find out why dividend seekers can confidently add Pfizer and Bristol Myers Squibb to their portfolios.  Pfizer has encountered some issues in recent years.  Sales of its coronavirus products fell off a cliff, and some of the company's older products are no longer the growth drivers they once were.",
      "url": "https://finnhub.io/api/news?id=e49c07fda0ea661a6e5e81095dc92044593bc5d97f96fe842cb5e9c09868ab3a"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B",
    "summary": "Pfizer divests its 7.3% remaining stake in Haleon to institutional investors and Haleon itself.",
    "url": "https://finnhub.io/api/news?id=f2fa0105aec61ace0aa4c3255ef6f4f49582b0c66c1075179a55998377d2b2b9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742474700,
      "headline": "Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B",
      "id": 133325259,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer divests its 7.3% remaining stake in Haleon to institutional investors and Haleon itself.",
      "url": "https://finnhub.io/api/news?id=f2fa0105aec61ace0aa4c3255ef6f4f49582b0c66c1075179a55998377d2b2b9"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer sells 7.3% stake in Haleon for $3.3bn",
    "summary": "The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.",
    "url": "https://finnhub.io/api/news?id=cabaa84b7f798963dc78f25f58259a975039364126beda7aff2b2759dacc2cee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742473104,
      "headline": "Pfizer sells 7.3% stake in Haleon for $3.3bn",
      "id": 133325260,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.",
      "url": "https://finnhub.io/api/news?id=cabaa84b7f798963dc78f25f58259a975039364126beda7aff2b2759dacc2cee"
    }
  },
  {
    "ts": null,
    "headline": "Buy 4 Ideal 'Safer' February Dividends, Out Of 40 Choices From Readers",
    "summary": "Discover top dividend-paying stocks with potential gains! Explore investment insights, high-yield underdogs, and safe picks for optimal portfolio growth.",
    "url": "https://finnhub.io/api/news?id=7236c47086f7af24ce7a9b6a9a76489aa8fa3a2bf6bd22ef9212929f2fcd8aca",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742469306,
      "headline": "Buy 4 Ideal 'Safer' February Dividends, Out Of 40 Choices From Readers",
      "id": 133281291,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/509640963/image_509640963.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover top dividend-paying stocks with potential gains! Explore investment insights, high-yield underdogs, and safe picks for optimal portfolio growth.",
      "url": "https://finnhub.io/api/news?id=7236c47086f7af24ce7a9b6a9a76489aa8fa3a2bf6bd22ef9212929f2fcd8aca"
    }
  },
  {
    "ts": null,
    "headline": "1 Reliable Dividend Stock You Can Buy Now and Hold at Least a Decade",
    "summary": "Market indexes have been falling as investors are beginning to assume President Trump will make good on repeated promises to raise the cost of goods entering the U.S. from the country's largest trading partners through tariffs.  Eliquis was responsible for 11.6% of Pfizer's total revenue in 2024.",
    "url": "https://finnhub.io/api/news?id=5c83eb754600f37ef1f996ae55ec7bc1d53669802d6357e5b8eb3ba77158e239",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742465820,
      "headline": "1 Reliable Dividend Stock You Can Buy Now and Hold at Least a Decade",
      "id": 133325261,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Market indexes have been falling as investors are beginning to assume President Trump will make good on repeated promises to raise the cost of goods entering the U.S. from the country's largest trading partners through tariffs.  Eliquis was responsible for 11.6% of Pfizer's total revenue in 2024.",
      "url": "https://finnhub.io/api/news?id=5c83eb754600f37ef1f996ae55ec7bc1d53669802d6357e5b8eb3ba77158e239"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys",
    "summary": "February investments fell below $1,000, mainly in BDCs like Owl Rock Capital and Ares Capital, boosting annual dividend income by $77.",
    "url": "https://finnhub.io/api/news?id=468f86fd4b412eee1971a4620667bbda7347c15c7444f076c7a1ef8f0edb1137",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742463648,
      "headline": "My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys",
      "id": 133276011,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "February investments fell below $1,000, mainly in BDCs like Owl Rock Capital and Ares Capital, boosting annual dividend income by $77.",
      "url": "https://finnhub.io/api/news?id=468f86fd4b412eee1971a4620667bbda7347c15c7444f076c7a1ef8f0edb1137"
    }
  },
  {
    "ts": null,
    "headline": "More Dividends, Less Drama: 3 Of My Favorite Dividend Stocks (5-7% Yield)",
    "summary": "Amid rising risks, I favor high-yield stocks with strong business models. Check out the stock picks that offer stability, solid dividends, and long-term potential.",
    "url": "https://finnhub.io/api/news?id=f3227573c13cd255e7d31b5c02dc54adeb88d5a82fb23d58008c6ec5ce806e8c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742455800,
      "headline": "More Dividends, Less Drama: 3 Of My Favorite Dividend Stocks (5-7% Yield)",
      "id": 133269476,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/170521142/image_170521142.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Amid rising risks, I favor high-yield stocks with strong business models. Check out the stock picks that offer stability, solid dividends, and long-term potential.",
      "url": "https://finnhub.io/api/news?id=f3227573c13cd255e7d31b5c02dc54adeb88d5a82fb23d58008c6ec5ce806e8c"
    }
  }
]